Indication
Treatment of advanced (unresectable or metastatic) melanoma in adolescents 12 years of age and older.

Medicine details

Medicine name:
ipilimumab (Yervoy)
SMC ID:
SMC2094
Pharmaceutical company
Bristol-Myers Squibb Pharmaceuticals Ltd
BNF chapter
Malignant disease and immunosuppression
Submission type
Abbreviated submission
Status
Advice due date:
08 October 2018
SMC meeting date:
04 September 2018